Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
5.13M
Cash
380.9K
Avg Qtr Burn
-4.336M
Short % of Float
5.45%
Insider Ownership
11.15%
Institutional Own.
8.44%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CTx-1301 Details Attention deficit hyperactivity disorder, Mental health | Phase 3 Update | |
CTx-1302 Details Mental health, Attention deficit hyperactivity disorder | Phase 1/2 Initiation | |
CTx-2103 (buspirone) Details Mental health, Anxiety Disorders | IND Submission |